Acadia Healthcare Company, Inc. (ACHC)
USD 39.05
(-1.49%)
USD 39.05
(-1.49%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 682.6 Million USD | -38.88% |
| 2022 | 1.11 Billion USD | 13.97% |
| 2021 | 979.88 Million USD | 15.53% |
| 2020 | 848.16 Million USD | -33.07% |
| 2019 | 1.26 Billion USD | 2.71% |
| 2018 | 1.23 Billion USD | 4.05% |
| 2017 | 1.18 Billion USD | 2.96% |
| 2016 | 1.15 Billion USD | 55.61% |
| 2015 | 740.09 Million USD | 94.37% |
| 2014 | 380.76 Million USD | 42.14% |
| 2013 | 267.87 Million USD | 80.6% |
| 2012 | 148.32 Million USD | 177.58% |
| 2011 | 53.43 Million USD | 170.65% |
| 2010 | 19.74 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 786.01 Million USD | 312.04% |
| 2024 Q1 | 174.59 Million USD | 2.35% |
| 2024 Q2 | 190.76 Million USD | 9.26% |
| 2023 Q3 | 723.18 Million USD | 127.02% |
| 2023 Q4 | 170.59 Million USD | -76.41% |
| 2023 Q2 | 318.56 Million USD | 10.97% |
| 2023 FY | 682.6 Million USD | -38.88% |
| 2023 Q1 | 287.06 Million USD | 1.19% |
| 2022 Q3 | 288.58 Million USD | 0.44% |
| 2022 Q1 | 257.19 Million USD | 3.14% |
| 2022 Q4 | 283.68 Million USD | -1.7% |
| 2022 FY | 1.11 Billion USD | 13.97% |
| 2022 Q2 | 287.3 Million USD | 11.71% |
| 2021 Q2 | 250.29 Million USD | 10.97% |
| 2021 Q4 | 249.35 Million USD | -2.1% |
| 2021 Q3 | 254.69 Million USD | 1.76% |
| 2021 Q1 | 225.54 Million USD | 3.74% |
| 2021 FY | 979.88 Million USD | 15.53% |
| 2020 Q1 | 310.52 Million USD | -2.98% |
| 2020 FY | 848.16 Million USD | -33.07% |
| 2020 Q2 | 292.58 Million USD | -5.78% |
| 2020 Q3 | 351.63 Million USD | 20.18% |
| 2020 Q4 | 217.4 Million USD | -38.17% |
| 2019 FY | 1.26 Billion USD | 2.71% |
| 2019 Q2 | 328.22 Million USD | 9.02% |
| 2019 Q3 | 317.86 Million USD | -3.16% |
| 2019 Q4 | 320.05 Million USD | 0.69% |
| 2019 Q1 | 301.08 Million USD | 0.35% |
| 2018 FY | 1.23 Billion USD | 4.05% |
| 2018 Q4 | 300.02 Million USD | -4.31% |
| 2018 Q3 | 313.53 Million USD | -1.67% |
| 2018 Q2 | 318.86 Million USD | 5.81% |
| 2018 Q1 | 301.34 Million USD | -1.03% |
| 2017 Q4 | 304.49 Million USD | 0.66% |
| 2017 Q1 | 275.06 Million USD | -5.02% |
| 2017 FY | 1.18 Billion USD | 2.96% |
| 2017 Q2 | 303.66 Million USD | 10.4% |
| 2017 Q3 | 302.5 Million USD | -0.38% |
| 2016 FY | 1.15 Billion USD | 55.61% |
| 2016 Q3 | 295.86 Million USD | -6.68% |
| 2016 Q1 | 249.1 Million USD | 20.37% |
| 2016 Q2 | 317.05 Million USD | 27.28% |
| 2016 Q4 | 289.61 Million USD | -2.11% |
| 2015 FY | 740.09 Million USD | 94.37% |
| 2015 Q4 | 206.93 Million USD | 3.63% |
| 2015 Q3 | 199.68 Million USD | 5.2% |
| 2015 Q2 | 189.81 Million USD | 32.13% |
| 2015 Q1 | 143.65 Million USD | 25.5% |
| 2014 Q4 | 114.46 Million USD | 2.4% |
| 2014 Q2 | 80.73 Million USD | 9.43% |
| 2014 Q3 | 111.78 Million USD | 38.46% |
| 2014 Q1 | 73.77 Million USD | 3.35% |
| 2014 FY | 380.76 Million USD | 42.14% |
| 2013 Q4 | 71.38 Million USD | 0.4% |
| 2013 Q1 | 58.26 Million USD | 35.96% |
| 2013 Q2 | 67.11 Million USD | 15.19% |
| 2013 FY | 267.87 Million USD | 80.6% |
| 2013 Q3 | 71.1 Million USD | 5.94% |
| 2012 Q2 | 95.65 Million USD | 10.15% |
| 2012 Q3 | 38.39 Million USD | -59.86% |
| 2012 Q1 | 86.84 Million USD | 236.19% |
| 2012 Q4 | 42.85 Million USD | 11.61% |
| 2012 FY | 148.32 Million USD | 177.58% |
| 2011 Q4 | 25.83 Million USD | 29.8% |
| 2011 Q2 | 1.23 Million USD | -92.23% |
| 2011 FY | 53.43 Million USD | 170.65% |
| 2011 Q1 | 15.91 Million USD | 392.66% |
| 2011 Q3 | 19.9 Million USD | 1508.73% |
| 2010 Q4 | 3.23 Million USD | -40.17% |
| 2010 Q3 | 5.39 Million USD | 0.0% |
| 2010 FY | 19.74 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Addus HomeCare Corporation | 339.87 Million USD | -100.841% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | -459.952% |
| Amedisys, Inc. | 457.07 Million USD | -49.342% |
| American Oncology Network, Inc. | 66.05 Million USD | -933.364% |
| Astrana Health, Inc. | 214.95 Million USD | -217.555% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | -14.641% |
| IMAC Holdings, Inc. | 3.84 Million USD | -17636.471% |
| biote Corp. | 127.48 Million USD | -435.451% |
| Cryo-Cell International, Inc. | 22.9 Million USD | -2880.645% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | -57.988% |
| COMPASS Pathways plc | -242.93 Thousand USD | 281080.744% |
| DocGo Inc. | 178.95 Million USD | -281.451% |
| The Ensign Group, Inc. | 590.75 Million USD | -15.548% |
| Healthcare Services Group, Inc. | 251.45 Million USD | -171.469% |
| InnovAge Holding Corp. | 132.06 Million USD | -416.877% |
| Assure Holdings Corp. | -2.19 Million USD | 31212.534% |
| The Joint Corp. | 107.14 Million USD | -537.06% |
| LifeStance Health Group, Inc. | 302.09 Million USD | -125.958% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 63797.306% |
| ModivCare Inc. | 446.95 Million USD | -52.725% |
| NewGenIvf Group Limited | 1.68 Million USD | -40488.363% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -13682.521% |
| Option Care Health, Inc. | 981.22 Million USD | 30.433% |
| P3 Health Partners Inc. | 31.63 Million USD | -2057.765% |
| P3 Health Partners Inc. | 31.63 Million USD | -2057.765% |
| The Pennant Group, Inc. | 61.9 Million USD | -1002.654% |
| Surgery Partners, Inc. | 529.4 Million USD | -28.94% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -48246.838% |
| Talkspace, Inc. | 74.38 Million USD | -817.732% |
| Talkspace, Inc. | 74.38 Million USD | -817.732% |
| The Oncology Institute, Inc. | 59.57 Million USD | -1045.836% |
| The Oncology Institute, Inc. | 59.57 Million USD | -1045.836% |